Patent Application
Utility
App. No. 16/505,295
· Confirmation No. 1925
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Applicant:
INFACARE PHARMACEUTICAL CORPORATION
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-08-14 | OATH |
Oath or Declaration filed | 75 | View | |
| 2020-09-18 | ABN |
Abandonment | 2 | View | |
| 2020-01-16 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2020-01-02 | CTNF |
Non-Final Rejection | 8 | View | |
| 2020-01-02 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-01-02 | 1449 |
List of References cited by applicant and considered by examiner | 15 | View | |
| 2020-01-02 | 1449 |
List of References cited by applicant and considered by examiner | 6 | View | |
| 2020-01-02 | 1449 |
List of References cited by applicant and considered by examiner | 7 | View | |
| 2020-01-02 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2019-10-11 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-10-11 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-10-08 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 6 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 49 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 183 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 48 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 48 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 12 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 135 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 5 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 3 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 5 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 32 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 36 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 49 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 27 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 18 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 36 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 15 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 62 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 43 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 30 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 35 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 37 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 24 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 67 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 20 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 36 | View | |
| 2019-10-08 | FOR |
Foreign Reference | 128 | View | |
| 2019-10-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 6 | View | |
| 2019-10-08 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 7 | View | |
| 2019-10-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 7 | View | |
| 2019-10-08 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 15 | View | |
| 2019-10-08 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 14 | View | |
| 2019-10-08 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 2 | View | |
| 2019-10-08 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 19 | View | |
| 2019-10-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2019-10-07 | DRW |
Drawings-only black and white line drawings | 16 | View | |
| 2019-10-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-10-07 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2019-10-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2019-10-07 | LET. |
Miscellaneous Incoming Letter | 2 | View | |
| 2019-08-07 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2019-08-07 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-08-07 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-07-08 | PA.. |
Power of Attorney | 2 | View | |
| 2019-07-08 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-07-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-07-08 | ABST |
Abstract | 1 | View | |
| 2019-07-08 | CLM |
Claims | 14 | View | |
| 2019-07-08 | SPEC |
Specification | 95 | View | |
| 2019-07-08 | ADS |
Application Data Sheet | 8 | View | |
| 2019-07-08 | OATH |
Oath or Declaration filed | 2 | View | |
| 2019-07-08 | DRW |
Drawings-only black and white line drawings | 16 | View | |
| 2019-07-08 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-07-08 | SPEC |
Specification | 1 | View | |
| 2019-07-08 | CLM |
Claims | 2 | View | |
| 2019-07-08 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View |
Inventors
Simon J. Tulloch
Gaithersburg, MD
Warren W. Wasiewski
Lancaster, PA
Attorneys & Agents of Record
Classification
USPC
600/301
A61K31/555
A61B5/48
A61B5/4839
A61N5/062
A61N5/0621
Prosecution
- Examiner
- ROGERS, JAMES WILLIAM
- Art Unit
- 1618
- Customer No.
- 5251
- Docket No.
- 12653.329634
- Confirmation No.
- 1925
Publication
- Pub. No.
- US20200016167A1
- Pub. Date
- 2020-01-16
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2026-04-10
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
RELEASE OF SECURITY INTEREST
Recorded 2025-08-14
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
SPECGX LLC,
OCERA THERAPEUTICS, INC.,
STRATATECH CORPORATION,
VTESSE LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
SUCAMPO PHARMA AMERICAS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536
Recorded 2023-11-16
MALLINCKRODT INTERNATIONAL FINANCE S.A.,
MALLINCKRODT CB LLC,
MALLINCKRODT FINANCE GMBH,
MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.),
MALLINCKRODT CARRIBEAN, INC.,
MALLINCKRODT US POOL LLC,
MNK 2011 LLC (F/K/A MALLINCKRODT INC.),
LUDLOW LLC (F/K/A LUDLOW CORPORATION),
CNS THERAPEUTICS, INC.,
MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.),
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
LAFAYETTE PHARMACEUTICALS LLC,
LIEBEL-FLARSHEIM COMPANY LLC,
MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.),
MALLINCKRODT VETERINARY, INC.,
MALLINCKRODT US HOLDINGS LLC,
IMC EXPLORATION COMPANY,
MEH, INC.,
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED),
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED),
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC (F/K/A VTESSE INC.),
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.),
INFACARE PHARMACEUTICAL CORPORATION,
ST SHARED SERVICES LLC,
THERAKOS, INC.,
IKARIA THERAPEUTICS LLC,
INO THERAPEUTICS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 051231, FRAME 0961
Recorded 2023-11-16
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
MALLINCKRODT LLC,
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY
Recorded 2022-06-22
OCERA THERAPEUTICS, INC.,
MALLINCKRODT LLC,
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED),
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED),
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY),
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE LLC (F/K/A VTESSE INC.)
RELEASE OF SECURITY INTEREST
Recorded 2022-06-17
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2022-06-17
from
MALLINCKRODT ARD IP LIMITED,
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE INC.
SECURITY INTEREST
Recorded 2019-12-10
from
MALLINCKRODT ARD IP LIMITED,
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING D.A.C.,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE INC.
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY
Recorded 2019-12-09
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-08-13
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/505,295
- Filed
- 2019-07-08
- Pub. No.
- US20200016167A1
- Examiner
- ROGERS, JAMES WILLIAM
- Art Unit
- 1618
External Links